Journal
CLINICAL INFECTIOUS DISEASES
Volume 64, Issue 9, Pages 1268-1270Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciw864
Keywords
gyrA; Neisseria gonorrhoeae; ciprofloxacin; antibiotic resistance
Categories
Funding
- David Geffen School of Medicine at UCLA
- National Institutes of Health [R21AI117256, R21AI109005]
Ask authors/readers for more resources
Multidrug-resistant Neisseria gonorrhoeae is a top threat to public health. In November 2015, UCLA Health introduced a rapid gyrase A (gyrA) genotypic assay for prediction of Neisseria gonorrhoeae susceptibility to ciprofloxacin. We found a significant reduction in ceftriaxone use with a concomitant increase in targeted therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
